Sian Bigora
Chief Development Officer at Processa Pharmaceuticals, Inc. (PCSA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$9K
Total bought / sold$21K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 19SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,9717,481 held (+36%) | $2.71 | $5K | -43.9% |
| May 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,9867,496 held (+36%) | $2.69 | $5K | -43.5% |
| Apr 17SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,7995,510 held (+48%) | $2.97 | $5K | -48.8% |
| Apr 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 2,1073,711 held (+131%) | $2.54 | $5K | -40.2% |
- Buy
Chief Development Officer Sian Bigora bought $5K of PCSA at $2.71 — raises the stake by 36%.
- Buy
Chief Development Officer Sian Bigora bought $5K of PCSA at $2.69 — raises the stake by 36%.
- Buy
Chief Development Officer Sian Bigora bought $5K of PCSA at $2.97 — raises the stake by 48%.
- Buy
Chief Development Officer Sian Bigora bought $5K of PCSA at $2.54 — first open-market purchase in our records; raises the stake by 131%.